The efficacy, safety, and feasibility of inhaled amikacin for the treatment of difficult-to-treat non-tuberculous mycobacterial lung diseases

BACKGROUND: In multidrug regimens, including an intravenous aminoglycoside (e.g. amikacin [AMK]) is recommended for difficult-to-treat non-tuberculous mycobacterial (NTM) lung diseases. We aimed to evaluate the efficacy, safety, and feasibility of inhaled AMK therapy in patients with difficult-to-tr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Infect Dis
Main Authors: Yagi, Kazuma, Ishii, Makoto, Namkoong, Ho, Asami, Takahiro, Iketani, Osamu, Asakura, Takanori, Suzuki, Shoji, Sugiura, Hiroaki, Yamada, Yoshitake, Nishimura, Tomoyasu, Fujiwara, Hiroshi, Funatsu, Yohei, Uwamino, Yoshifumi, Kamo, Tetsuro, Tasaka, Sadatomo, Betsuyaku, Tomoko, Hasegawa, Naoki
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5550988/
https://ncbi.nlm.nih.gov/pubmed/28793869
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-017-2665-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados